SCHEMBL8890250

SCHEMBL8890250

NCC1CCCC(CNc2nc(N)c3ccccc3n2)C1

nearest known ligand 0.66

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ NPY5R Q15761 7/20 0.66
▸ AQP1 P29972 2/20 0.53
▸ ALDH1A1 P00352 1/20 0.53
▸ ADRA2A P08913 1/20 0.53
▸ MAPT P10636 1/20 0.53
▸ HPGD P15428 1/20 0.53
▸ NPY1R P25929 1/20 0.53
▸ NPY2R P49146 1/20 0.53
▸ NPY4R P50391 1/20 0.53
▸ MCHR1 Q99705 1/20 0.53
▸ TDP1 Q9NUW8 1/20 0.53
▸ APP P05067 11/20 0.52
▸ SLC6A4 P31645 2/20 0.52
▸ MEN1 O00255 1/20 0.44
▸ KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8892683 0.95 NPY5R (0.60) NPY5RAQP1ALDH1A1ADRA2AMAPT
SCHEMBL2636281 0.87 NPY5R (0.64) NPY5RAQP1ALDH1A1ADRA2AMAPT
Hydrochloric Acid SCHEMBL8906965 0.86 NPY5R (0.62) NPY5RAQP1ALDH1A1ADRA2AMAPT
Hydrochloric Acid SCHEMBL2675360 0.86 NPY5R (0.62) NPY5RAQP1ALDH1A1ADRA2AMAPT
SCHEMBL8890247 0.83 NPY5R (0.61) NPY5RAQP1ALDH1A1ADRA2AMAPT
SCHEMBL8908378 0.80 NPY5R (0.64) NPY5RAQP1ALDH1A1ADRA2AMAPT
SCHEMBL6674509 0.80 NPY5R (0.60) NPY5RAQP1ALDH1A1ADRA2AMAPT
SCHEMBL8898901 0.79 NPY5R (0.49) NPY5RAQP1ALDH1A1ADRA2AMAPT
SCHEMBL2804108 0.79 NPY5R (0.62) NPY5RAQP1ALDH1A1ADRA2AMAPT
SCHEMBL8899497 0.79 NPY5R (0.62) NPY5RAQP1ALDH1A1ADRA2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997020823-A2 2-AMINO QUINAZOLINE DERIVATIVES AS NPY RECEPTOR ANTAGONISTS NOVARTIS AG (CH) 1997-06-12 — — WO claimed
WO-1997020823-A2 2-AMINO QUINAZOLINE DERIVATIVES AS NPY RECEPTOR ANTAGONISTS NOVARTIS AG (CH) 1997-06-12 — — WO disclosed
Send feedback